NCT01743404

Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis

Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Institute for Atherosclerosis Research, Russia · Academic / Other
• Sex: Male
• Age: 40 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the anti-atherosclerotic effect of long-term anti-inflammatory therapy (Inflaminat) in asymptomatic participants with subclinical atherosclerosis of carotid arteries.

Conditions

• Carotid Atherosclerosis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Inflaminat
DRUG	Placebo	Sugar pill manufactured to mimic Inflaminat 500 mg tablet

Timeline

• Start date: 2007-09-01
• Primary completion: 2013-02-01
• Completion: 2013-06-01
• First posted: 2012-12-06
• Last updated: 2012-12-06

Locations

1 site across 1 country: Russia